Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata

References

• Betz RC, Petukhova L, Ripke S, et al. Genome wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun. 2015;6:5966.
   PubMed Web of Science ®Google Scholar
• Zaher H, Gawdat HI, Hegazy RA, et al. Bimatoprost versus mometasone furoate in the treatment of scalp alopecia areata: a pilot study. Dermatology. 2015;230:308–313.
   PubMed Web of Science ®Google Scholar
• Oro A, Dolmetsch RE, Yucel G. Compositions for increasing hair growth. FPO; 2015. doi: 10.1080/09546634.2017.1330527.
   Google Scholar
• Lenane P, Macarthur C, Parkin PC, et al. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children. J Am Acad Dermatol. 2014;150:47–50.
   Google Scholar
• Dermlite. Available from com/products/dermlite-ii-pro-hr. Accessed January 12, 2014.
   Google Scholar
• Olsen EA, Hordinsky MK, Price VH, et al. Alopecia areata investigational assessment guidelines. part II. J Am Acad Dermatol. 2004;51:440–7.
   PubMed Web of Science ®Google Scholar
• Thelen U, Schnober D, Schölzel S, et al. Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany. Int J Ophthalmol. 2013;6:155–9.
   PubMed Web of Science ®Google Scholar
• Zaher H, Gawdat H. Bimatoprost: a potential therapeutic tool for alopecia areata of the scalp. J Egy Women Dermatol Society. 2014;11:123–7.
   Google Scholar
• Coronel-Pérez IM, Rodríguez-Rey EM, et al. Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis. J Eur Acad Dermatol Venereol. 2010;24:481–5.
   PubMed Web of Science ®Google Scholar
• Vila TO, Camacho Martinez FM. Bimatoprost in the treatment of eyelash universalis alopecia areata. Int J Trichol. 2010;2:86–8.
   PubMedGoogle Scholar
• Faghihi G, Andalib F, Asilian A. The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows. Eur J Dermatol. 2009;19:586–7.
   PubMed Web of Science ®Google Scholar
• Roseborough I, Lee H, Chwalek J, et al. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata. J Am Acad Dermatol. 2009;60:705–6.
   PubMed Web of Science ®Google Scholar
• Ochoa BE, Sah D, Wang G, et al. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata. J Am Acad Dermatol. 2009;61:530–2.
   PubMed Web of Science ®Google Scholar
• Colombe L, Vindrios A, Michelet JF, et al. Prostaglandin metabolism in human hair follicle. Exp Dermatol. 2007;16:762–9.
   PubMed Web of Science ®Google Scholar
• Bernard BA, Michelet JF, Colombe L. Prostanoid receptors in anagen human hair follicles. Exp Dermatol. 2008;17:63–72.
   PubMed Web of Science ®Google Scholar
• Torii E, Segi E, Sugimoto Y. Expression of prostaglandin E2 receptor subtypes in mouse hair follicles. Biochem Biophys Res Commun. 2002;290:696–700.
   PubMed Web of Science ®Google Scholar
• Wolf R, Matz H, Zalish M, Pollack A, etet al. Prostaglandin analogs for hair growth: great expectations. Dermatol Online J. 2003;9:7.
   PubMedGoogle Scholar
• Johnstone MA, Albert DM. Prostaglandin-induced hair growth. Surv Ophthalmol. 2002;47:S185–S202.
   PubMed Web of Science ®Google Scholar
• Blume-Peytavi U, Lönnfors S, Hillmann K, et al. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. J Am Acad Dermatol. 2012;66:794–800.
   PubMed Web of Science ®Google Scholar
• Sardesai VR, Prasad S, Agarwal TD. A study to evaluate the efficacy of various topical treatment modalities for alopecia areata. Int J Trichol. 2012;4:265–70.
   PubMedGoogle Scholar
• Aman S, Nadeem M. Comparison of the efficacy and safety of topical 5% minoxidil solution alone and in combination with 0.05% betamethasone dipropionate cream in the treatment of alopecia areata. Special Edition Ann. 2010;16:100–3.
   Google Scholar
• Hogade A, Hussain AA. Comparison of efficacy of various topical treatment modalities in alopecia areata. J Evolution Med Dental Sci. 2015;4:2127–34.
   Web of Science ®Google Scholar
• Vanderveen EE, Ellis CN, Kang S. Topical minoxidil for hair regrowth. J Am Acad Dermatol. 1984;11:416–21.
   PubMed Web of Science ®Google Scholar
• Fransway AF, Muller SA. 3 Percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata. Cutis. 1988;41:431–5.
   PubMed Web of Science ®Google Scholar
• Herskovitz I, Freedman J, Tosti A. Minoxidil induced hypertrichosis in a 2 year-old child. F1000Res. 2013;2:226.
   PubMedGoogle Scholar
• Fiedler VC, Wendrow A, Szpunar GJ, et al. Treatment resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin. Arch Dermatol. 1990; 126:756–9.
   Google Scholar
• Buhl AE. Minoxidil’s action in hair follicles. J Invest Dermatol. 1991;96:73–4.
   Web of Science ®Google Scholar
• Olsen EA, Dunlap FE, Funicella T. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47:377–85.
   PubMed Web of Science ®Google Scholar
• Fiedler-Weiss VC. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata. J Am Acad Dermatol. 1987;16:745–8.
   PubMed Web of Science ®Google Scholar
• Weiss VC, West DP. Topical minoxidil therapy and hair regrowth. Arch Dermatol. 1985;121:191–2.
   PubMedGoogle Scholar
• Kuldeep CM, Singhal H, Khare AK, et al. Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata. Int J Trichol. 2011;3:20–4.
   PubMedGoogle Scholar
• Mancuso G, Balducci A, Casadio C, et al. Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial. Int J Dermatol. 2003;42:572–5.
   PubMed Web of Science ®Google Scholar
• Ross EK, Shapiro J. Management of hair loss. Dermatol Clin. 2005;23:227–43.
   PubMed Web of Science ®Google Scholar
• Tosti A, Piraccini BM, Pazzaglia M, et al. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol. 2003;49:96–8.
   PubMed Web of Science ®Google Scholar
• Ganjoo S, Thappa DM. Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata. Indian J Dermatol Venereol Leprol. 2013;79:408–17.
   PubMed Web of Science ®Google Scholar
• Ranchoff RE, Bergfeld WF, Steck WD, Subichin SJ. Extensive alopecia areata. Results of treatment with 3% topical minoxidil. Cleveland Clin J Med. 1989;56:49–54.
   Web of Science ®Google Scholar
• Fenton DA, Wilkinson JD. Topical minoxidil in the treatment of alopecia areata. Br Med J. 1983;287:1015–17.
   PubMed Web of Science ®Google Scholar